Eyes are one of the most vital sensory organs and is second most complex after brain. It is a vulnerable organ with various disorders that can threaten its structure, function or both. Ophthalmology is a branch of medicine and surgery which deals with the diagnosis and treatment of eye disorders. Some of the most common eye disorders are refractive errors such as myopia, hyperopia, presbyopia, and astigmatism; glaucoma, ocular infections and inflammation such as conjunctivitis, blepharitis, keratitis; dry eye; cataract; and retinal diseases.
Treatment paradigm of eye disorders primarily aims to reduce inflammation, repairs traumatic injuries, and improves or saves eyesight. Treatment comprises of medication, surgery, prescription glasses or contact lenses and treatment of systemic conditions affecting eye. Prevalence of eye disorders has been increasing incessantly. This is expected to boost global ophthalmic market. Furthermore, other factors such as rising R&D in the industry, growing geriatric population and increasing awareness are also expected to drive growth. However, the market faces various challenges due to high cost of diagnosis & treatment, patent expiration of blockbuster ophthalmic drugs and limited insurance coverage.
The report “Global Ophthalmology Market (By Segment – Surgical & Vision Care; By Disease - Retinal Disorder, Glaucoma & Dry Eye; By Drug Class – Anti Glaucoma Drugs, Dry Eye Drugs & Anti-infective Drugs; By Region – North America, Europe & Asia Pacific) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global ophthalmology market with market segmentation across indications such as Retinal Disorder, Glaucoma & Dry Eye; drug classes such as – Anti Glaucoma Drugs, Dry Eye Drugs & Anti-infective Drugs. Future forecasts of ophthalmology market overall and across various market segments has been provided in the report till 2025. Furthermore, major industry players have been prudently analysed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global ophthalmology market include Novartis AG, Bausch & Lomb, Inc., F.Hoffman La-Roche, Regeneron Pharmaceuticals, Inc., Allergan PLC, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global ophthalmology market market.
Ophthalmic drug delivery has been one of the most daunting task for clinicians. With the advent of novel drug delivery techniques, unique delivery systems of drug administration has been introduced into the market. Novel dosage form mainly comprises of microemulsions, nanosuspensions, dendrimers, niosomes, liposomes etc.
The report “Global Ophthalmology Market (By Segment – Surgical & Vision Care; By Disease - Retinal Disorder, Glaucoma & Dry Eye; By Drug Class – Anti Glaucoma Drugs, Dry Eye Drugs & Anti-infective Drugs; By Region – North America, Europe & Asia Pacific) Market Outlook 2025” provides in-depth analysis of the current scenario, detailed market outlook of the global ophthalmology market overall as well as across market segments such as by disease and by drug class for the period 2019-25. Regional analysis is done across major markets in North America, Europe and Asia Pacific.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global ophthalmology market. The report has been segmented as following:-
Market Segmentation – Segments
• Surgical
• Vision Care
Market Segmentation – Disease
• Retinal Disorder
• Glaucoma
• Dry Eye
Market Segmentation – Drug Class
• Anti-Glaucoma Drugs
• Dry Eye Drugs
• Anti-Infective Drugs
Geographical Coverage
• North America – The US
• Europe – Germany & The UK
• Asia Pacific – China & India
Key Vendors
• Novartis AG
• Bausch & Lomb, Inc.
• F.Hoffman La-Roche
• Regeneron Pharmaceuticals, Inc.
• Allergan PLC
1. Executive Summary
2. Research Methodology
3. Ophthalmology
3.1 Background
3.2 Eye Disorders
4. Market Analysis
4.1 Market Sizing (Actual & Forecasted)
4.2 Market Share Analysis
4.2.1 Market Share by Segment
4.2.2 Market Share by Indication
4.2.3 Market Share by Drug Class
4.2.4 Market Share by Products
4.2.5 Market Share by Product Type
4.2.6 Market Share by Dosage Type
4.2.7 Market Share by Region
5. Market Segmentation
5.1 Segments
5.1.1 Surgical
5.1.1.1 Market Sizing (Actual & Forecasted)
5.1.1.2 Implantable Market Sizing (Actual & Forecasted)
5.1.1.3 Consumables Market Sizing (Actual & Forecasted)
5.1.1.3 Equipment/Others Market Sizing (Actual & Forecasted)
5.1.2 Vision Care
5.1.2.1 Market Sizing (Actual & Forecasted)
5.1.2.2 Contact Lenses Market Sizing (Actual & Forecasted)
5.1.2.3 Contact Lenses Market Sizing (Actual & Forecasted)
5.2 Disease
5.2.1 Retinal Disorder
5.2.1.1 Market Sizing (Actual & Forecasted)
5.2.1.2 Market Share by Disease Type
5.2.1.3 nAMD Market Sizing (Actual & Forecasted)
5.2.1.4 DME/DR Market Sizing (Actual & Forecasted)
5.2.1.5 DME/DR Market Sizing (Actual & Forecasted)
5.2.2 Glaucoma
5.2.2.1 Market Sizing (Actual & Forecasted)
5.2.3 Dry Eye
5.2.3.1 Market Sizing (Actual & Forecasted)
5.3 Drug Class
5.3.1 Anti-Glaucoma Drugs
5.3.2 Dry Eye Drugs
5.3.3 Anti-Infective Drugs
6. Regional Analysis
6.1 North America
6.1.1 Market Sizing (Actual & Forecasted)
6.1.2 The US
6.1.2.1 Market Sizing (Actual & Forecasted)
6.1.2.2 Market Share by Dosage Type
6.1.2.3 Market Share by End-Users
6.2 Europe
6.2.1 Market Sizing (Actual & Forecasted)
6.2.2 Germany
6.2.2.1 Market Sizing (Actual & Forecasted)
6.2.3 The UK
6.2.2.1 Market Sizing (Actual & Forecasted)
6.3 Asia Pacific
6.3.1 Market Sizing (Actual & Forecasted)
6.3.2 China
6.3.2.1 Market Sizing (Actual & Forecasted)
6.3.4 India
6.3.4.1 Market Sizing (Actual & Forecasted)
6.3.4.2 Market Share by Devices
7. Market Dynamics
7.1 Industry Trends & Development
7.1.1 Mergers & Acquisitions
7.1.2 Advent of Novel Drug Delivery Techniques
7.2 Growth Drivers
7.2.1 Prevalence of Eye Disorder
7.2.3 Rising R&D in the Industry
7.2.4 Growing Geriatric Population
7.2.5 Increasing Awareness
7.3 Challenges
7.3.1 High Cost of Diagnosis & Treatment
7.3.2 Patent Expiration of Blockbuster Ophthalmic Drugs
7.3.3 Limited Insurance Coverage
8. Competitive Landscape
8.1 Market Share Analysis
8.2 Financial Analysis
9. Company Profiles
9.1 Novartis AG
9.2 Bausch & Lomb, Inc.
9.3 F.Hoffman La-Roche
9.4 Regeneron Pharmaceuticals, Inc.
9.5 Allergan PLC
List of Tables
Table 1: Analysis of Various Ocular Disorders
Table 2: Drugs Administered for Diagnosis and Treatment of Ocular Disorders
Table 3: Mergers & Acquisitions in Ophthalmic Market
Table 4: Global Ophthalmic Market – Revenue Forecast by Companies, FY2018-FY2022E (US$ Billions)
Table 5: Global Ophthalmic Market – Financial Analysis of Leading Companies
Table 6: Novartis AG Ophthalmic Drugs Clinical Pipeline
Table 7: Bausch & Lomb, Inc. Number of Drugs by Indication
Table 8: Bausch & Lomb, Inc. Bausch & Lomb, Inc. Clinical Drug Pipeline
Table 9: F.Hoffman La-Roche Ophthalmic Clinical Pipeline
Table 10: Regeneron Pharmaceuticals, Inc. Ophthalmic Clinical Pipeline
Table 11: F.Hoffman La-Roche Ophthalmic Clinical Pipeline
List of Figures
Figure 1: Rockville Research – Research Methodology
Figure 2: Global Ophthalmic Drugs Market Size by Value, 2016-25E (US$ Billions)
Figure 3: Global Ophthalmic Market Share by Segment (2018)
Figure 4: Global Ophthalmic Drugs Market Share by Indication (2018)
Figure 5: Global Ophthalmic Drugs Market Share by Drug Class (2018)
Figure 6: Global Ophthalmic Devices Market Share by Products (2018)
Figure 7: Global Ophthalmic Drugs Market Share by Product Type (2081)
Figure 8: Global Ophthalmic Drugs Market Share by Dosage Type (2018)
Figure 9: Global Ophthalmic Market Share by Region (2018)
Figure 10: Global Ophthalmic Surgical Devices Market Size by Value, 2017-25E (US$ Billions)
Figure 11: Global Ophthalmic Surgical Devices – Implantable Market Size by Value, 2017-25E (US$ Billions)
Figure 12: Global Ophthalmic Surgical Devices – Consumables Market Size by Value, 2017-25E (US$ Billions)
Figure 13: Global Ophthalmic Surgical Devices – Equipment/Others Market Size by Value, 2017-25E (US$ Billions)
Figure 14: Global Ophthalmic – Vision Care Market Size by Value, 2017-25E (US$ Billions)
Figure 15: Global Ophthalmic Vision Care – Contact Lenses Market Size by Value, 2017-25E (US$ Billions)
Figure 16: Global Ophthalmic Vision Care – Ocular Health Market Size by Value, 2017-25E (US$ Billions)
Figure 17: Global Ophthalmic Disease – Retinal Disorder Drugs Market Size by Value, 2017-25E (US$ Billions)
Figure 18: Global Ophthalmic – Retinal Disorder Drugs Market Share by Disease Type (2018)
Figure 19: Global Ophthalmic – Retinal Disorder nAMD Drugs Market Size by Value, 2017-25E (US$ Billions)
Figure 20: Global Ophthalmic – Retinal Disorder DME/DR Drugs Market Size by Value, 2017-25E (US$ Billions)
Figure 21: Global Ophthalmic – Retinal Disorder RVO Drugs Market Size by Value, 2017-25E (US$ Billions)
Figure 22: Global Ophthalmic Diseases – Glaucoma Drugs Market Size by Value, 2017-25E (US$ Billions)
Figure 23: Global Ophthalmic Diseases – Dry Eye Drugs Market Size by Value, 2017-25E (US$ Billions)
Figure 24: Global Ophthalmic Market – Anti-Infective Drugs Market Size by Value, 2018-25E (US$ Billions)
Figure 25: Global Ophthalmic Market – Dry Eye Drugs Market Size by Value, 2018-25E (US$ Billions)
Figure 26: Global Ophthalmic Market – Anti-Infective Drugs Market Size by Value, 2018-25E (US$ Billions)
Figure 27: North America Ophthalmic Market Size by Value, 2016-25E (US$ Billions)
Figure 28: The US Ophthalmic Drugs Market Size by Value, 2016-25E (US$ Billions)
Figure 29: The US Ophthalmic Drugs Market Share by Dosage Type (2018)
Figure 30: The US Ophthalmic lasers market share, by end-use
Figure 31: Europe Ophthalmic Market Size by Value, 2016-25E (US$ Billions)
Figure 32: Germany Ophthalmic Market Size by Value, 2016-25E (US$ Billions)
Figure 33: The UK Ophthalmic Market Size by Value, 2016-25E (US$ Billions)
Figure 34: Asia Pacific Ophthalmic Drugs Market Size by Value, 2016-25E (US$ Billions)
Figure 35: China Ophthalmic Market Size by Value, 2017-25E (US$ Billions)
Figure 36: India Ophthalmic Market Size by Value, 2017-25E (US$ Billions)
Figure 37: India Ophthalmic Devices Market Share by Device Type (2018)
Figure 38: Prevalence and Projections of Eye Disorders, 2017 & 2030E (Millions)
Figure 39: Global Ageing (Aged 65 years and above) Population, 2013-18 (Millions)
Figure 40: Incidence of Eye-Diseases with Age (%)
Figure 41: Global Ophthalmic Medtech Market Share by Companies (2018 & 2025E)
Figure 42: Global Ophthalmic Surgery Market Share by Companies (2018)
Figure 43: Novartis AG Revenue by Business Segment (FY2018)
Figure 44: Novartis AG Net Sales, FY2015-FY2018 (US$ Billions)
Figure 45: Bausch & Lomb, Inc. Revenue by Business Segment (FY2018)
Figure 46: Bausch & Lomb, Inc. Net Sales, FY2015-FY2018 (US$ Millions)
Figure 47: F.Hoffman La-Roche Revenue by Business Segment (FY2018)
Figure 48: F.Hoffman La-Roche Net Sales, FY2015-FY2018 (US$ Billions)
Figure 49: Regeneron Pharmaceuticals, Inc. Revenue by Business Segment (FY2018)
Figure 50: Regeneron Pharmaceuticals - EYLEA (aflibercept) Sales, FY2012-FY2018
Figure 51: Regeneron Pharmaceuticals, Inc. Net Sales, FY2015-FY2018 (US$ Billions)
Figure 52: F.Hoffman La-Roche Revenue by Business Segment (FY2018)
Figure 53: F.Hoffman La-Roche Net Sales, FY2015-FY2018 (US$ Billions)
Novartis AG
Bausch & Lomb, Inc.
F.Hoffman La-Roche
Regeneron Pharmaceuticals, Inc.
Allergan PLC
*If Applicable.
Links
[1] https://www.marketresearchreports.com/countries/north-america[2] https://www.marketresearchreports.com/countries/europe[3] https://www.marketresearchreports.com/countries/asia-pacific[4] https://www.marketresearchreports.com/pharma-healthcare[5] https://www.marketresearchreports.com/diagnostics[6] https://www.marketresearchreports.com/diseases[7] https://www.marketresearchreports.com/medical-supplies